Steve K Hwang, MD in East Point, GA - Surgery

Steve K Hwang, MD is a Surgery physician based in East Point, Georgia. Steve K Hwang is licensed to practice in Georgia (license number 021723) and his current practice location is 1136 Cleveland Ave Ste 408, East Point, Georgia. He can be reached at his office (for appointments etc.) via phone at (404) 669-9080.

NPI number for Steve K Hwang is 1871566877 and his current mailing address is P.o. Box 962650, Riverdale, Georgia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1871566877.

Contact Information

	Steve K Hwang, MD
	1136 Cleveland Ave Ste 408, East Point, GA 30344-3618
	(404) 669-9080
	(404) 669-9059

Physician's Profile

Full Name	Steve K Hwang
Gender	Male
Speciality	Surgery
Location	1136 Cleveland Ave Ste 408, East Point, Georgia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1871566877
Provider Enumeration Date: 02/09/2006
Last Update Date: 10/04/2011

Medical Identifiers

Medical identifiers for Steve K Hwang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1871566877	NPI	-	NPPES
000200846A	Medicaid	GA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	021723 (Georgia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steve K Hwang is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Steve K Hwang, MD P.o. Box 962650, Riverdale, GA 30296-6926 Ph: (404) 669-9080	Steve K Hwang, MD 1136 Cleveland Ave Ste 408, East Point, GA 30344-3618 Ph: (404) 669-9080

News Archive

Formatech selects Tracon Pharmaceuticals' TRC102 inhibitor as next Fillanthropy Program candidate

Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE 2 Phase I/IIa study indicate that treatment with four weeks of the Company's investigative immune-modulator, recombinant human Interleukin-7, added to peginterferon and ribavirin in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC, induces a broad immune response associated with HCV viral clearance in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC.

University of Gothenburg studies reveal that linalyl acetate can trigger allergic eczema

Linalyl acetate, a fragrance chemical that is one of the main constituents of the essential oil of lavender, is not on the list of allergenic compounds pursuant to the EU Cosmetics Directive. Thus, it does not need to be declared on cosmetic products sold within the EU. Recent studies at the University of Gothenburg have shown that linalyl acetate can cause allergic eczema.

Finger length may predict prostate cancer

In a new study published in the British Journal of Cancer, researchers have revealed a connection between finger length and prostate cancer. It says that men whose ring fingers are longer than their index fingers are more likely to develop prostate cancer.

FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection

Watson Pharmaceuticals, Inc. today announced that Amphastar Pharmaceuticals, Inc., has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium Injection in the 100mg/mL and 150mg/mL strengths.

Surgery Doctors in East Point, GA

Dr. Olufemi A Babalola, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1513 Cleveland Ave Bldg 500, East Point, GA 30344 Phone: 404-752-1000
Mrs. Carolyn Yvonne Singleton-russell, CSFA/BSHA/HM Surgery Medicare: Not Enrolled in Medicare Practice Location: 1514 East Cleveland Avenue, Suite 117, East Point, GA 30344 Phone: 770-715-4651 Fax: 770-985-4258
Dr. Vijaykumar G. Patel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Avenue, Ste 513, East Point, GA 30344 Phone: 404-466-6500 Fax: 404-466-7211
Irwin M Best, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1170 Cleveland Ave, East Point, GA 30344 Phone: 404-305-3500

Steve K Hwang, MD - Surgery in East Point, GA